We have our surgeon in the panel.

Yeah, thank you for being here.

Peter kindly said, you know, he has been around for a long time, which is just another expression for being old.

But I think particularly HER2 subtype is a role model in many respects.

Number one, for what we have achieved.

I'm actually old enough to remember that HER2 overexpression was a poor prognosis sign, poor response to chemo, and bad prognosis.

And this has completely changed.

And with that, I would turn over the floor to Michael to continue with the adjuvant part of the story.

We have our surgeon in the panel.

Yeah, thank you for being here.

Peter kindly said, you know, he has been around for a long time, which is just another expression for being old.

But I think particularly HER2 subtype is a role model in many respects.

Number one, for what we have achieved.

I'm actually old enough to remember that HER2 overexpression was a poor prognosis sign, poor response to chemo, and bad prognosis.

And this has completely changed.

And with that, I would turn over the floor to Michael to continue with the adjuvant part of the story.